Bill lets some drugs be sold as supplements without FDA approval.

What it does

The bill changes when drug ingredients can go into dietary supplements. It allows drugs in clinical trials to be added to supplements. This applies if trials have not been active for seven or more years. It allows drugs sold as supplements before drug testing to return to supplements. The bill makes the FDA prove in court that a supplement breaks the law. It removes the requirement for supplement makers to prove safety.

Who it affects

Dietary supplement makers and ingredient suppliers would face fewer rules. Consumers could buy more supplement-drug combinations. The FDA would have less power to stop unapproved drugs from being sold as supplements.

One thing to notice

The bill shifts who must prove safety in court. The FDA would have to prove supplements are unsafe. Makers would not have to prove they are safe.

From the analysis of the bill text, linked under Primary records below.

Where it stands

• Sep 10, 2026 — Introduced · Congress.gov: “Introduced in House”
• Sep 10, 2026 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Words to know

• dietary supplements — Pills, powders, or liquids with vitamins, minerals, herbs, or other ingredients people take by mouth.
• clinical trials — Tests of new drugs on people to see if they work and are safe.
• FDA — The Food and Drug Administration, the U.S. agency that checks if drugs and foods are safe.